Navigation Links
Stent Studies Tied to Rapid Changes in Use
Date:7/28/2009

Fast dissemination of data may become main stimulus for change, experts say

TUESDAY, July 28 (HealthDay News) -- Rapid dissemination of new data about the risks posed by drug-eluting stents led to an almost immediate decrease in the use of the stents, according to a new report.

Drug-eluting stents are coated with drugs meant to prevent re-narrowing of coronary arteries.

An analysis of patient registries showed that between January and September 2006, about 90 percent of people who had a type of heart attack called a non-ST-elevation myocardial infarction and underwent coronary stent implantation received drug-eluting stents.

That September, a number of studies presented at a European Society of Cardiology meeting said that the risk of blood clots was higher among people who received drug-eluting stents than among those who received bare-metal stents.

By the end of March 2007, the use of drug-eluting stents had declined to 67 percent and continued to drop to 58 percent by the start of 2008, the researchers found. Their study is published online in Circulation: Cardiovascular Quality and Outcomes.

"There was a rapid change of practice patterns after these presentations in September 2006," the study's lead author, Dr. Matthew T. Roe, an associate professor of medicine at Duke University Medical Center and the Duke Clinical Research Institute in Durham, N.C., said in an American Heart Association news release. "To our knowledge, this was the most rapid change in practice patterns in cardiology. We presume it was because of rapid uptake of information."

The findings suggest that fast distribution of new information through media and scientific outlets could become the "predominant stimulus for change in practice in the future," Roe and his colleagues said.

Dr. Clyde W. Yancy, president of the American Heart Association, said in the news release that the study "demonstrates the dynamic shifts that are occurring in the distribution of medical information."

"The opportunity to widely share important findings that promptly impact practice is becoming a powerful tool to drive change," Yancy said. "The requirements for prompt but thorough peer review and nimble responsiveness to new data are evident. Managing this new health IT space will require focus, assessment and realignment."

More information

The Society for Vascular Surgery has more about angioplasty and stenting.



-- Robert Preidt



SOURCE: American Heart Association, news release, July 28, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. QHR Client Hospitals Lauded for Consistently High Quality Standards, Exceeding Patient Expectations
2. FDA Approves Boston Scientifics TAXUS(R) Liberte(R) Long Stent
3. AbbeyMoor Medical Receives FDA Approval for Design Improvements to The Spanner(TM) Prostatic Stent
4. CorNova(R) Receives CE Mark Approval for Valecor Platinum(R) Coronary Stent System
5. Abbott Receives CE Mark for Companys Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
6. Newest Coated Stent Does Well in Real-World Trial
7. AMA Supports Health System Reform Alternatives Consistent With Principles of Pluralism, Freedom of Choice, Freedom of Practice and Universal Access for Patients
8. Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use
9. InstaMed Achieves CAQH CORE Rules Certification, Streamlines Provider Access to Consistent Electronic Eligibility, Benefits and Patient Financial Liability Data
10. Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
11. Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stent Studies Tied to Rapid Changes in Use
(Date:1/15/2017)... ... January 15, 2017 , ... Going above ... program that strives to better communities around the world by offering the Gensuite ... provides the opportunity for team members to become involved in a cause that ...
(Date:1/15/2017)... ... January 15, 2017 , ... San Francisco Magazine ... Bay Area counties for 2017. Almost 1,000 nominations were submitted and a little ... process. Results were announced the magazine’s January 2017 issue . , Under ...
(Date:1/14/2017)... ... January 14, 2017 , ... Healthy ... expanding line of activated charcoal products. With more and more people opting to ... products according to how they cater to specific needs. , Moody Zook focused ...
(Date:1/13/2017)... ... January 13, 2017 , ... People ... levels. Counting carbohydrates is as easy as checking the nutrition label on foods ... blood sugar levels. Despite being sugar-free, proteins can influence — either positively or ...
(Date:1/13/2017)... ... , ... With the increasing public preference for chemical-free personal ... alternatives for customers who have grown more conscious about maintaining their health and ... charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg explained their company’s decision ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... YORK , Jan. 16, 2017 ... Densitometers Market Outlook to 2022", provides key market data ... provides value, in millions of US dollars, volume (in ... Dual Energy X-Ray Absorptiometry (DEXA) and Quantitative Ultrasound (QUS). ... shares data for each of these market segements, and ...
(Date:1/16/2017)... 16, 2017  Verathon ® Inc., a leading manufacturer and ... new GlideScope ® Spectrum TM Single-Use video laryngoscopes. ... and Ambient Light Reduction TM technology, which actively optimizes ... ... Introducing another bright idea ...
(Date:1/16/2017)... , Jan. 16, 2017 When synthetic Fentanyl ... market their product as top-rate. They offered free samples, inviting ... customer service. Soon, business was booming. ... described as 100 times more powerful than morphine, has racked ... in last 2 years. One dealer,s recorded fentanyl sales ...
Breaking Medicine Technology: